Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

As Fight For Shelf Space Accelerates, OTC Brands Must Be Flexible

This article was originally published in The Pink Sheet Daily

Executive Summary

Rite Aid looks for innovative products likely to prompt category growth, but quality alone is not enough to secure a strong foothold, exec says.

You may also be interested in...



GNC, Rite Aid expansion plans

GNC and Rite Aid announce Aug. 7 an agreement that will nearly double the number of GNC LiveWell locations within Rite Aid stores nationwide by 2014. Under the contract, the firms expect 1,125 GNC locations to be added to the 1,300 currently operating inside Rite Aid stores; the agreement also provides Rite Aid with an option to extend the contract through 2019 and open 250 more stores during that time period. Rite Aid plans to add "several hundred" GNC store-within-Rite Aid store locations during its fiscal year, ending March 1, 2008...

COVID-19 Deter Class Actions? No. Plaintiffs' Attorneys Have Time For More Complaints? Yes.

Class action complaints filed in 2020 against food, dietary supplement and beverage firms should pass 2019’s total as COVID-19 has not slowed litigants but has given plaintiffs’ council more time out of court to shop for new cases.

US Meeting Set For CBDs’ Impact On Pregnancies, Gender-Specific Biological, Psychosocial Effects

FDA schedules public meeting for 19 November to discuss sex and gender differences in the use and response to cannabidiols. The meeting will address the issue of CBD use in pregnancy, for which no human data currently is available.

Topics

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel